|
All approvals by the Local Ethics Committees (LECs)
in charge of the trial sites must be obtained prior to the regulatory
submission. The LEC’s approval process is limited by law to
one month.
The regulatory process takes 60 days for phase I to III and 30 days
for phase IV (period legally limited), and includes an ethical evaluation.
A detailed listing of documents requested has been published. The
applicant may be either the sponsor, its legal representative or
the coordinating investigator, but the form must be filled in in
Bulgarian. Any objection or request for more information may prolong
the approval process.
An international standard patient insurance is acknowledged but
an additional insurance protecting investigators against patients'
claims must be concluded.
Customs clearance is not issued automatically with the approval
but is granted upon request for each shipment separately.
Overall approval time is up to 90 days for phases I to III, 60 days
for phase IV.
Health
care system
Private physicians provide basic care only and refer patients to
hospitals’ outpatient departments or specialists. Clinical
trials are permitted to be performed only at hospitals authorised
by the state authorities, not at private doctors' offices. Therefore,
a large patient pool of a specific indication can be found centralised
in hospitals, some of them in charge of a population of several
hundred thousand.
Infrastructure
Highway access to major towns, no fast inter-city train system available
(average speed 80 – 100 km/h), air traffic (both national
and international) currently concentrated at the airports in Sofia,
Burgas, Varna and Plovdiv.
Clinical
Trials Management
Since its establishment in 1991, ECRON/Convex has conducted more than 135 Phase
I-IV clinical trials. ECRON/Convex collaborates with all significant investigational
units in Bulgaria, including local regulatory authorities, BDA and Ministry of Health.
Good professional contacts have been created with the managing staff of the hospitals
in Bulgaria, and with specialised laboratories, courier services, customs, etc. Bulgaria
is joining the EU from 1 January 2007. At present a new Law on Drugs and Pharmacies
in Human Medicine is being discussed in the Bulgarian Parliament that should be effective
as of 1 January 2007.
Local
office/staff
ECRON - Convex, 59 Vitosha Blvd., Sofia 1000, Bulgaria
Phone: +359 (0) 2 986 3109 Fax: +359 (0) 2 988 8700
Email: bd@ecronacunova.com
Links
Official
EU enlargement pages
Authority:
Bulgarian Drug Agency BDA
Drugs
registered in BG
LECs
authorised by MoH
|